Szarkóma: vizsgálatok itt: Olaszország
52 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleSTART: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
- Where
- Candiolo, Milan, Naples, Rozzano
- Életkor
- 18 év and over
- People
- 15 worldwide
- Run by
- Valo Therapeutics Oy
See details and how to joinNCT05492682 · EU 2024-517580-23-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
- Where
- Bergamo, Florence, Milan, Modena, Monza, Perugia, Peschiera del Garda, Rome, Turin
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07541170 · EU 2025-524263-21-01 - 2. fázisTaking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Milan, Reggio Emilia, Rome
- Életkor
- 18 év and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - No phaseTaking peopleObservational Study in Localized Osteosarcoma
- Where
- Aviano, Bari, Bologna, Candiolo, Catania, Florence, Genova, Milan, Padova, Palermo, Pisa, Roma, Trieste
- Életkor
- Up to 40 év
- People
- 120
- Run by
- Italian Sarcoma Group
See details and how to joinNCT04890067 - 2. fázisTaking peopleClinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS
- Where
- Candiolo, Milan, Padova, Prato, Rome
- Életkor
- 15 év and over
- People
- 20 worldwide
- Run by
- Italian Sarcoma Group
See details and how to joinNCT07328425 · EU 2024-519261-21-00 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Milan, Rome, Turin
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - 1. fázisTaking peoplePhase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- Where
- Milan
- Életkor
- 24 hónap to 18 év
- People
- 20 worldwide
- Run by
- ITM Solucin GmbH
See details and how to joinNCT06441331 · EU 2024-512831-66-00 - 3. fázisTaking peopleA Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
- Where
- Aviano, Leghorn, Milan, Naples, Padova, Ravenna, Rome
- Életkor
- 18 év and over
- People
- 348 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06345729 · EU 2023-507776-42-00 - 3. fázisTaking peopleFight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
- Where
- Bologna, Genova, Milan, Padova, Pisa, Roma, Torino
- Életkor
- 4 év and over
- People
- 530 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07871864 - 3. fázisTaking peopleSurgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
- Where
- Aviano, Candiolo, Meldola, Milan, Padova, Roma
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04031677 - 1/2. fázisTaking peopleA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Where
- Milan
- Életkor
- Up to 25 év
- People
- 75 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00 - 1. fázisTaking peoplePhase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Where
- Candiolo, Milan
- Életkor
- 12 év to 85 év
- People
- 411 worldwide
- Run by
- Inhibrx Biosciences, Inc
See details and how to joinNCT03715933 · EU 2023-508139-29-00 - 1/2. fázisTaking peoplePhase I-II prospective trial, multicenter, open label, exploring the combination of Trabectedin plus RAdiotherapy in Soft Tissue Sarcoma patients
- Where
- Aviano, Candiolo, Milan
- Életkor
- 18 év and over
- People
- 163 worldwide
- Run by
- Asoc Grupo Espanol De Investigacion En Sarcomas
See details and how to join2024-518199-30-00 · EU 2024-518199-30-00 - 2. fázisTaking peopleKEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
- Where
- Meldola, Milan, Rome
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07252739 · EU 2025-521939-36-00 - 1. fázisTaking peopleLong-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies
- Where
- Milan
- People
- 7 worldwide
- Run by
- USWM Ct LLC
See details and how to join2024-513033-21-00 · EU 2024-513033-21-00 - 3. fázisTaking peopleA Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
- Where
- Bergamo, Bologna, Candiolo, Milan, Padova, Palermo, Rome
- Életkor
- 18 év and over
- People
- 333 worldwide
- Run by
- Intensity Therapeutics, Inc.
See details and how to joinNCT06263231 · EU 2024-512423-36-00 - No phaseTaking peopleIdentification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas
- Where
- Bologna
- People
- 16
- Run by
- Istituto Ortopedico Rizzoli
See details and how to joinNCT07685405 - 1/2. fázisTaking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Aviano, Milan, Rome
- Életkor
- 12 év and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - No phaseTaking peopleClinical Management and Outcomes of Primary Ovarian Leiomyosarcoma
- Where
- Avellino, Catania, Milan, Modena, Monza, Naples, Parma, Reggio Emilia, Verona
- Életkor
- 18 év to 99 év
- People
- 30
- Run by
- Azienda USL Reggio Emilia - IRCCS
See details and how to joinNCT06749600 - No phaseTaking peopleElectrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
- Where
- Padova
- Életkor
- 18 év to 99 év
- People
- 24
- Run by
- Istituto Oncologico Veneto IRCCS
See details and how to joinNCT06753136 - No phaseTaking peopleThe Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
- Where
- Bologna, Careggi, Milan, Orbassano, Padova, Palermo, Prato, Roma, Rozzano
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT06408441 - 2. fázisTaking peopleStudy on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma
- Where
- Bologna, Candiolo, Milan, Palermo, Prato, Rome
- Életkor
- 16 év and over
- People
- 16
- Run by
- Italian Sarcoma Group
See details and how to joinNCT04305548 · EU 2024-514319-85-00 - 2. fázisTaking peopleTrial in Patients With Metastatic or Locally Advanced Leiomyosarcoma
- Where
- Aviano, Bologna, Candiolo, Genova, Meldola, Milan, Naples, Orbassano, Padova, Palermo, Prato, Roma, Rome, Rozzano, Torino
- Életkor
- 18 év and over
- People
- 100
- Run by
- Italian Sarcoma Group
See details and how to joinNCT04383119 - 3. fázisTaking peoplePhase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
- Where
- Milan, Palermo, Rome
- Életkor
- 18 év and over
- People
- 325 worldwide
- Run by
- Advenchen Laboratories, LLC
See details and how to joinNCT03016819 - 2. fázisNot yet taking people in OlaszországPhase II Prospective Multicenter Study of High-Dose Treosulfan/Melphalan as Consolidation Treatment in Newly Diagnosed High-Risk and Very High-Risk Ewing Sarcoma
- Where
- Ancona, Bari, Naples, Pisa, Roma, Verona, Azienda Ospedaliero-Universitaria di Modena (AOU Modena) - Policlinico di Modena
- Életkor
- Up to 64 év
- People
- 60
- Run by
- Fondazione Santobono Pausilipon Onlus
See details and how to join2024-518912-37-01 · EU 2024-518912-37-01